Abstract
Castleman's disease is a rare lymphoproliferative disorder of poorly understood etiology. It is most commonly located in the mediastinum. Castleman's disease mimicking adrenal neoplasm is a very rare differential diagnosis and unusual presentation. We report a rare suprarenal unicentric hyaline vascular variant of the disease in a 16-year-old boy with atypical symptoms mimicking an adrenal neoplasm.
KEYWORDS: Adrenal gland neoplasm, Castleman's disease, lymphoproliferative disorder
INTRODUCTION
Castleman's disease is a rare disorder, first defined by Castleman in 1956 as a distinct clinicopathological entity.[1] Two-thirds are located in the mediastinum and rest occur at extrathoracic locations such as axilla, neck, groin, mesentery, and retroperitoneal space. It is classified based on the clinical presentation and histopathological variant. The clinical subtypes are unicentric and multicentric. The histopathological variants are hyaline vascular, plasma cell, and mixed type.[2] We hereby report a case of hyaline vascular variant at the adrenal gland.
CASE REPORT
A 16-year-old boy presented with dull pain in the left upper abdomen with weight loss of 10 kg over 4 months. He had no significant past medical or surgical history. Physical examination revealed nontender, soft abdomen, without palpable mass or peripheral lymphadenopathy. Contrast enhanced computer tomography (CECT) scan of chest and abdomen showed a lobulated, well-circumscribed, enhancing mass of 53 mm × 51 mm × 55 mm with necrotic area, occupying the left suprarenal region [Figure 1]. There is no significant mediastinal mass or retroperitoneal lymph nodes. Laboratory tests and 24-h urine vanillylmandelic acid and metanephrines and plasma metanephrines were normal. He was taken up for surgery with a provisional diagnosis of nonfunctioning adrenal neoplasm. Intraoperatively, a mass of 5.5 cm × 5 cm × 6 cm was located in the left suprarenal region with multiple feeding vessels from the aorta and the left renal artery. Adrenal gland was not separately made out from the mass and it was removed en bloc. Grossly, the mass was well encapsulated with grayish white cut surface area. Histopathology revealed lymphoid follicles with thickened mantle zones and lymphocytes arranged in concentric rings [Figure 2]. There was vascular proliferation and hyalinization of vessel wall, based on which diagnosis of hyaline vascular Castleman's disease was made. His postoperative recovery was uneventful and no adjuvant therapy was considered. He is on regular follow-up without recurrence and disease free at 6 months.
Figure 1.

Contrast enhanced computed tomography of abdomen showing lobulated, circumscribed, enhancing left suprarenal mass with area of necrosis. Adrenal gland is not separately seen
Figure 2.

Photomicroscopy shows lymphoid follicles arranged in a concentric fashion with hyalinization and adjacent hyalinized blood vessels. (Hematoxylin and Eosin, ×10)
DISCUSSION
Castleman's disease is a rare neoplasm occurring most commonly in the mediastinum. Only 12% cases occur in the abdomen of which only 12 cases have been reported previously in the adrenal region [Table 1].[3,4,5,6,7,8,9,10,11,12,13] The etiology of Castleman's disease is poorly understood with one possible hypothesis being a defect in the immune regulation.[2]
Table 1.
Reported cases of adrenal region Castleman’s disease
| Author | Age (years)/sex | Presenting symptom | Longest size (cm) | CT finding | Intraoperative finding |
|---|---|---|---|---|---|
| Debatin et al.[3] | 43/female | Hypertension | 6 | Homogenous enhancement | Adrenal gland replaced by disease |
| Gupta et al.[4] | 25/male | Vague upper gastrointenstinal symptoms | 8 | Calcified lesion | Adrenal replaced by disease |
| Chen et al.[5] | 51/female | Poor appetiteLoss of weight | 5.2 | Well-defined enhancing mass with multiple areas of low attenuation | Mass separate from adrenal |
| Mussig et al.[6] | 51/male | OverweightHypertension | 3 | Homogenous enhancement | Adrenal gland invasion with multiple lymph node |
| Santomauro et al. (2011)[7] | 16/male | Incidentaloma | 4.8 | Enhancing mass | Mass separate from adrenal gland |
| Otto et al.[8] | 33/male | Incidentaloma | 5 | Small focus of enhanced density | Tumor separate from adrenal |
| Cao et al.[9] | 51/female | Abdominal pain | 11 | Enhancing mass | NA |
| Cao et al.[9] | 56/male | Incidentaloma | 8 | Heterogenous mass | NA |
| Hong et al.[10] | 65/female | Abdominal discomfortHypertension | 5 | Highly enhancing mass with peripheral enhancement, multiple lymph nodes | Adrenal replaced by disease with multiple nodes |
| Sundar et al.[11] | 44/female | Abdominal pain | 6.7 | Well defined with heterogenous enhancement | Mass separate from adrenal |
| Chen et al.[12] | 26/female | Left flank pain | 4 | Non enhancing mass | Adrenal replaced by disease |
| Guo et al.[13] | 59/male | Abdominal pain | 5.1 | Enhancing heterogenous mass | Mass adhered to surrounding structures |
| Our case | 16/male | Abdominal pain, weight loss | 5.5 | Enhancing heterogenous mass | Adrenal replaced by disease |
CT – Computed tomography, NA – Not available
The age of presentation in suprarenal disease has ranged from 16 years to 65 years without gender predilection. The most common presenting symptom for unicentric disease in suprarenal region has been abdominal pain although many have presented as incidentalomas.[3,4,5,6,7,8,9,10,11,12,13] In our case, the patient is a 16-year-old male and presented with weight loss and abdomen pain which is an uncommon presentation for the localized unicentric hyaline vascular type Castleman's disease. In view of age, symptoms and high geographical burden, a differential diagnosis of tuberculosis was also kept, however, majority of patients with active or recently acquired tubercular disease (<2 years) have bilateral adrenal enlargement, while calcification and atrophy are visualized in more remote infection or inactive disease.[14]
Although imaging plays a key role in the identification of adrenal masses, it may not be conclusive in identifying Castleman's disease. Various authors have reported features of well-defined enhancing solid mass with homogenous soft tissue density, calcified lesion or with multiple lymph nodes on CECT.[10] Our patient had a heterogenous mass with necrotic areas. One author has described MR features of adrenal disease as hypointense in T1 and hyperintense in T2 with a delayed washout although they emphasized that similar features can be seen in lymphoma also.[3]
The hyaline vascular type accounts for 80%–90% of localized disease and is usually asymptomatic but may cause pressure effect due to large size and is rarely associated with systemic features.[4] As in mediastinum, three different disease patterns are seen in suprarenal region also: solitary noninvasive mass; a dominant infiltrative mass with associated lymphadenopathy; matted lymphadenopathy without a dominant mass.[15] In other sites, a solitary noninvasive mass is the most common presentation, but in the suprarenal region, 50% patients had adrenal gland infiltration. In our case, the mass was 6 cm with lobulations but well encapsulated without any infiltration of adjacent structures. Such findings are also seen in other adrenal malignancies also.
Castleman's disease involving a single site is usually benign, however, multicentric variety can transform into malignant lymphoma.[2] The treatment of unicentric hyaline vascular Castleman's disease is complete surgical excision which is curative.[13] Our case of 16-year-old boy with symptomatic presentation and uncommon computed tomography findings illustrates a divergent presentation of this rare pathology and need for histopathological confirmation.
CONCLUSION
The unicentric hyaline vascular variety of Castleman's disease masquerading as an adrenal neoplasm is a very rare presentation. It is to be considered in the differential diagnosis of nonfunctional adrenal neoplasm.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
- 1.Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9:822–30. doi: 10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
- 2.Henry K, Symmers WSC. Systemic Pathology: Thymus, Lymph Nodes, Spleen and Lymphatics. Vol. 7. Edinburgh: Churchill Livingstone; 1992. pp. 207–18. [Google Scholar]
- 3.Debatin JF, Spritzer CE, Dunnick NR. Castleman disease of the adrenal gland: MR imaging features. AJR Am J Roentgenol. 1991;157:781–3. doi: 10.2214/ajr.157.4.1892035. [DOI] [PubMed] [Google Scholar]
- 4.Gupta NP, Ansari MS, Chopra P, Dinda AK. Castleman's disease masquerading as an adrenal tumor. J Urol. 2002;168:2524. doi: 10.1016/S0022-5347(05)64182-1. [DOI] [PubMed] [Google Scholar]
- 5.Chen JH, Yu CY, Pai CY, Chan DC, Chen CJ, Yu JC, et al. Castleman's disease in the left upper retroperitoneal space mimicking an adrenal neoplasm: Report of a case and literature review. Jpn J Clin Oncol. 2005;35:353–6. doi: 10.1093/jjco/hyi092. [DOI] [PubMed] [Google Scholar]
- 6.Mussig K, Horger M, Wehrmann M. Adrenal castleman's disease. Ann Hematol. 2007;86:63–5. doi: 10.1007/s00277-006-0200-7. [DOI] [PubMed] [Google Scholar]
- 7.Santomauro M, Choe C, Heimbigner J, Roberts J, Auge B. Castleman's disease in the left suprarenal region, mimicking an adrenal neoplasm. Urology. 2011;78:319. doi: 10.1016/j.urology.2010.12.031. [DOI] [PubMed] [Google Scholar]
- 8.Otto M, Wieprzowski T, Dzwonkowski J, Ziakiewicz-Wroblewska B. Castleman's disease – An unusual indication for laparoscopic adrenalectomy. Wideochir Inne Tech Maloinwazyjne. 2012;7:50–4. doi: 10.5114/wiitm.2011.25620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Cao DH, Liu LR, Xu RH, Jiang D, Lv X, Yuan HC, et al. Retroperitoneal laparoscopic management method of Castleman's disease in the adrenal gland: Two cases report and review of the literature. Int J Clin Exp Med. 2014;7:5909–12. [PMC free article] [PubMed] [Google Scholar]
- 10.Hong SB, Lee NM, Kim S, Han GJ, Ha HK, Ku JY, et al. Adrenal Castleman's disease mimicking other adrenal neoplasms: A case report. J Korean Soc Radiol. 2017;76:73–7. [Google Scholar]
- 11.Sundar P, Bijalwan P, Pooleri GK. Castleman's disease: A suprarenal surprise! Indian J Surg Oncol. 2018;9:254–5. doi: 10.1007/s13193-018-0737-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Chen J, Yang C, Liang C. Detection of a unicentric type of castleman-like mass at the site of adrenal gland: A case report and review of literature. World J Clin Cases. 2018;6:683–7. doi: 10.12998/wjcc.v6.i13.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Guo L, Sang Z, Du J, Zhang Q, Meng H, Shi B, et al. A case report of adrenal Castleman's disease. SN Compr Clin Med. 2019;1:479–82. [Google Scholar]
- 14.Kelestimur F. The endocrinology of adrenal tuberculosis: The effects of tuberculosis on the hypothalamo-pituitary-adrenocortical function. J Endocrinol Invest. 2004;27:380–6. doi: 10.1007/BF03351067. [DOI] [PubMed] [Google Scholar]
- 15.Meador TL, McLarney JK. CT features of castleman disease of the abdomen and pelvis. AJR Am J Roentgenol. 2000;175:115–8. doi: 10.2214/ajr.175.1.1750115. [DOI] [PubMed] [Google Scholar]
